AVTR
Avantor, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #504
- Final score
- 50.06
- Years on list
- 7
↗ Climbed 159 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 159 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 327 since 2021
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 303 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | AVTR | RGEN | WST |
|---|---|---|---|
| Climate Change | 62.1 | 61.6 | 47.4 |
| Employee Relations | 48.6 | 48.3 | 42.9 |
| Environment | 43.8 | 46.4 | 50.5 |
| Stakeholders & Society | 54.6 | 51.6 | 70.2 |
| Human Rights | 41.5 | 51.5 | 38.7 |
| Governance | 39.7 | 40.7 | 45.4 |
| Performance Rating | 51.7 | 51.6 | 55.3 |